Prazosin for Raynaud's phenomenon in progressive systemic sclerosis

BACKGROUND: Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have raynaud's phenomenon (RP). One of the possible treatment options for RP in scleroderma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Harding, Sarah E, Tingey, Paul C, Pope, Janet, Fenlon, D, Furst, Dan, Shea, Beverley, Silman, Alan, Thompson, A, Wells, George A
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 1998
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032637/
https://ncbi.nlm.nih.gov/pubmed/10796398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000956
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars